G01N 2800/321
Arterial hypertension
G01N2800/321 (Arterial hypertension) appears on 86 US grants and 141 published applications in this corpus.
Search patents in G01N- Granted patents
- 86
- Published applications
- 141
- Assignees
- 97
- Inventors
- 276
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 2 |
| 2002 | 2 | 1 |
| 2003 | 3 | 4 |
| 2004 | 0 | 4 |
| 2005 | 1 | 7 |
| 2006 | 3 | 8 |
| 2007 | 2 | 4 |
| 2008 | 3 | 5 |
| 2009 | 2 | 7 |
| 2010 | 3 | 5 |
| 2011 | 6 | 15 |
| 2012 | 2 | 8 |
| 2013 | 6 | 7 |
| 2014 | 4 | 3 |
| 2015 | 3 | 9 |
| 2016 | 5 | 5 |
| 2017 | 3 | 8 |
| 2018 | 5 | 8 |
| 2019 | 5 | 2 |
| 2020 | 1 | 4 |
| 2021 | 3 | 4 |
| 2022 | 3 | 6 |
| 2023 | 2 | 5 |
| 2024 | 3 | 4 |
| 2025 | 2 | 1 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic small molecules for treatment of pulmonary hypertension14 Apr 2026US 12,599,592 B2The Texas A&M University System
- Broad-spectrum nanoparticle enabled genomic detection13 Jan 2026US 12,522,874 B2The Regents of the University of California
- Nanoparticle probes and methods of making and use thereof21 Oct 2025US 12,447,215 B2
- Aptamer for specifically recognizing soluble ST2 protein and application of the same7 Jan 2025US 12,188,022 B2Beijing Inst of Heart Lung & Blood Vessel Diseases
- Pulmonary hypertension biomarker18 Jun 2024US 12,012,636 B2Novartis AG
- Compositions and methods for treating diseases and conditions associated with activation of the nlrp3 inflammasome1 Oct 2026US 2026/0297180 A1
- Methods for prognosis and monitoring pulmonary hypertension23 Jul 2026US 2026/0210973 A1Assistance Publique-HôPitaux De Paris (Aphp)
- Biomarkers for diagnosis and treatment of endocrine hypertension, and methods of identification thereof28 May 2026US 2026/0148848 A1Assistance Publique-Hopitaux de Paris
- Methods of treating hypertension in obese subjects26 Feb 2026US 2026/0053811 A1Mineralys Therapeutics, Inc.
- Methods of treating hypertension with a combination of an aldosterone synthase inhibitor and a diuretic26 Feb 2026US 2026/0053812 A1Mineralys Therapeutics, Inc.
Most cited
By later US patents
- Method for identifying an agent which increases TGF-beta levels87US 5,595,722 ANeoRx Corporation · 1997
- Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells60US 5,545,569 ANeoRx Corporation · 1996
- Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells49US 5,599,844 ANeoRx Corporation · 1997
- Method for evaluating and treating hypertension49US 6,632,180 B12003
- Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells43US 5,472,985 ANeoRx Corporation · 1995